Dong Liu

This inventor holds 9 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Kind Pharmaceutical, Zhejiang University, Hangzhou Phecdamed Co., Ltd.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Liu. Retrieved from https://idiyas.com/inventor/dong-liu-v7gnl67f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 8)

% Patents Active = 88.9

EPO Patents = 2 (Patent Applications = 15)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 4(Granted Patents)

Location History:

Zhejiang, CN (2019)
Hangzhou, CN (2021 - 2024)

Company Filing History:

Hangzhou Phecdamed Co., Ltd.

patent

Years Active: 2019-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12712006 - READING METHOD AND READING CIRCUIT OF FRAM (2026-08-18),

2. 12151999 - Small molecule compounds having naphthylamine structure and application thereof (2024-11-26),

3. 11970495 - Indolizine derivatives and their application in medicine (2024-04-30),

4. 11945817 - Indolizine derivatives and their application in medicine (2024-04-02),

5. 11718615 - Heterocyclic compounds and their application in medicine (2023-08-08),

6. 11655249 - Indolizine derivatives and their application in medicine (2023-05-23),

7. 11236088 - Heterocyclic compounds and their application in medicine (2022-02-01),

8. 11021478 - Indolizine derivatives and their application in medicine (2021-06-01),

9. 10444160 - Surface defects evaluation system and method for spherical optical components (2019-10-15),

Title: The Innovative Contributions of Dong Liu

Introduction

Dong Liu is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of medicinal chemistry, holding a total of 9 patents. His work focuses on developing novel compounds with potential therapeutic applications.

Latest Patents

One of his latest patents is titled "Small molecule compounds having naphthylamine structure and application thereof." This application discloses small molecule compounds that can selectively induce autophagy in damaged mitochondria, demonstrating superior metabolic stability and lower toxicity. Another notable patent is "Indolizine derivatives and their application in medicine." This invention relates to novel substituted indolizine derivatives and their use in various medical applications.

Career Highlights

Dong Liu has worked with several companies, including Kind Pharmaceutical and Hangzhou Phecdamed Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Throughout his career, Dong Liu has collaborated with notable colleagues, including Dongdong Chen and Biao Deng. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Dong Liu's contributions to medicinal chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His innovative work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.